Interim CEO and CSO Lori Yang presented two posters and gave a talk on GlycoSenseTM: A Rapid Method for Monitoring In Vitro Glycoengineering. Learn more about the 2018 ASBMB Annual Meeting here.
Interim CEO and CSO Lori Yang presents at the 2018 ASBMB Annual Meeting
